InvestorsHub Logo
Followers 2
Posts 115
Boards Moderated 0
Alias Born 04/18/2015

Re: andy55q post# 7012

Thursday, 04/30/2015 11:00:07 AM

Thursday, April 30, 2015 11:00:07 AM

Post# of 27409
Hi Andy, many thanks again from my side for this link as well other informative links/reports on successfull CTSO therapy cases.

It shows again, that there is an unchanged high potential for the filter. In order they can improve significantly the materialization, some short term triggers will help, that is the approval in the US and the recent engagment of Dr. Scheier from the SORIN Group. I guess you mentioned that SORIN has a 50% market share in its core market (medical supplies).
The good network Dr. Schleier brings on the table will help a lot to achieve the set goals to increase faster awareness, clinical data and finally the sales numbers.
On top, there might be a cooperation between CTSO/Sorin. Imagine that Sorin can open many doors to CTSO in its large client base.
Later on a take-over can not be exclued. If you look at the history of the SORIN Group (http://de.wikipedia.org/wiki/Sorin_Group (in german there are more data avaiable), you see that some part of their growth is due to take-overs. Sorin is listed on the Milan stock exchange:
http://finance.yahoo.com/echarts?s=SRN.MI+Interactive#{%22range%22%3A%22max%22%2C%22scale%22%3A%22linear%22}

Employees: 3750 (July 2013)
Tunrover: 738 Mio. EUR (2013)
Profit: 59 Mio. EUR (2013)

There is a reason why Dr. Scheier joined CTSO...

A cooperation would be of mutual benefit. Sorin could help CTSO to further materialize a huge market that is to accellerate the entrance for a billion market. For CTSO, they would get a much faster access to their marekt/to the joint target market.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News